Generics Drug Report 2014

As a result of the patent cliff, generic drug manufacturers have thrived while branded pharmaceutical manufacturers have suffered. Branded pharmaceutical manufacturers are expected to suffer even more in the coming years, as many more important patents will lose exclusivity. 

A recent paper from the Centers for Medicare and Medicaid Services delves into these issues and more.